Discover
CLB
Core Laboratories N.V.
12.44
1 x 10.06
1 x 13.02
bid
ask
+
0.22
1.80%
1 @ 03:59 PM
12.43 -0.01 (0.08%)
| Ytd | -22.40% | |
| 1y | 27.72% |
12.17
day range
12.52
9.79
52 week range
20.36
| Open | 12.22 | Prev Close | 12.22 | Low | 12.17 | High | 12.52 | Mkt Cap | 573.44M |
| Vol | 338.88K | Avg Vol | 849.35K | EPS | 0.68 | P/E | 18.29 | Forward P/E | 17.18 |
| Beta | 2.36 | Short Ratio | 23.15 | Inst. Own | 112.62% | Dividend | 0.04 | Div Yield | 0.24 |
| Ex Div Date | 11-04 | Earning | 07-29 | 50-d Avg | 11.76 | 200-d Avg | 15.34 | 1yr Est | 19.33 |
| Income Statement | |||
| Total Revenue | 124.61M | ||
| Revenues (USD) | 124.61M | ||
| Cost of Revenue | 101.37M | ||
| Gross Profit | 23.24M | ||
| Operating Expenses | 14.09M | ||
| Selling, General and Administrative Expense | 10.95M | ||
| Operating Income | 9.15M | ||
| Interest Expense | 2.85M | ||
| Income Tax Expense | 507.00K | ||
| Net Income | 5.96M | ||
| Net Income Common Stock | 5.96M | ||
| Net Income Common Stock (USD) | 5.96M | ||
| Consolidated Income | 5.80M | ||
| Net Income to Non-Controlling Interests | -158.00K | ||
| Earnings per Basic Share | 0.13 | ||
| Earnings per Basic Share (USD) | 0.13 | ||
| Earnings per Diluted Share | 0.12 | ||
| Dividends per Basic Common Share | 0.01 | ||
| Earning Before Interest & Taxes (EBIT) | 9.31M | ||
| Earning Before Interest & Taxes (USD) | 9.31M | ||
| Weighted Average Shares | 46.03M | ||
| Weighted Average Shares Diluted | 46.88M | ||
| Balance Sheet | |||
| Cash and Equivalents | 22.74M | ||
| Cash and Equivalents (USD) | 22.74M | ||
| Trade and Non-Trade Receivables | 108.82M | ||
| Current Assets | 214.36M | ||
| Property, Plant & Equipment Net | 153.26M | ||
| Total Assets | 586.78M | ||
| Debt Current | 11.94M | ||
| Total Debt | 165.12M | ||
| Current Liabilities | 101.05M | ||
| Debt Non-Current | 153.18M | ||
| Total Liabilities | 308.01M | ||
| Accumulated Retained Earnings (Deficit) | 176.91M | ||
| Accumulated Other Comprehensive Income | -5.68M | ||
| Shareholders Equity | 272.67M | ||
| Shareholders Equity (USD) | 272.67M | ||
| Assets Non-Current | 372.42M | ||
| Total Debt (USD) | 165.12M | ||
| Deferred Revenue | 5.08M | ||
| Goodwill and Intangible Assets | 112.55M | ||
| Inventory | 57.96M | ||
| Liabilities Non-Current | 206.96M | ||
| Trade and Non-Trade Payables | 40.16M | ||
| Tax Assets | 77.84M | ||
| Tax Liabilities | 12.68M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.83M | ||
| Net Cash Flow from Financing | -3.96M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -84.00K | ||
| Capital Expenditure | -4.18M | ||
| Issuance (Purchase) of Equity Shares | -2.69M | ||
| Issuance (Repayment) of Debt Securities | -625.00K | ||
| Payment of Dividends & Other Cash Distributions | -460.00K | ||
| Net Cash Flow from Investing | -3.93M | ||
| Net Cash Flow from Operations | 7.81M | ||
| Share Based Compensation | 902.00K | ||